Amedisys is being acquired by UnitedHealth for $3.3B, pending DOJ approval. Learn why UNH and AMED stock are impacted by ...

Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...

UnitedHealth outbid several competitors to scoop up Amedisys, with the deal first coming to light in late June 2023. Should ...

Home health company Amedisys, based in Louisiana and Nashville, fell short of estimates in its third quarter earnings report.

For the quarter ended September 2024, Amedisys (AMED) reported revenue of $587.67 million, up 5.7% over the same period last year. EPS came in at $1.00, compared to $0.98 in the year-ago quarter. The ...

UnitedHealth (UNH) and Amedisys (NASDAQ:AMED) are expected to meet with Dept. of Justice officials in a final effort to ...

UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Net service ...

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.

Amedisys (AMED) delivered earnings and revenue surprises of -12.28% and 0.08%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?